Canopy Growth Corporation (CGC) Stock Score, Valuation & Financial Research
Canopy Growth Corporation is in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 24/100.
Quick answer for CGC
Canopy Growth Corporation currently has a Wall Street Score of 24/100. The stored market price is $0.94. Its financial score is 25/100. Its valuation score is 0/100. The latest WSS change is +0.1 points. These figures are a research snapshot, not a buy or sell recommendation.
What Canopy Growth Corporation does
Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divisions: Global Cannabis and a diverse portfolio of Other Consumer Products. Its extensive product range features dried cannabis flower, various extracts and concentrates, infused beverages, edible gummies, and vape cartridges. Canopy Growth distributes these items under numerous well-known brands, such as Tweed, 7ACRES, Martha Stewart CBD, and Spectrum Therapeutics, among others. Originally founded as Tweed Marijuana Inc., the enterprise adopted its current name, Canopy Growth Corporation, in Sep
CGC financial snapshot
- Wall Street Score:
- 24/100
- Current price:
- $0.94
- Market capitalization:
- $398.0M
- Revenue:
- $231.8M
- Net income:
- $-187.0M
- Free cash flow:
- $-50.3M
- Cash:
- $242.8M
- Total debt:
- $200.0M
- EPS:
- -0.44
- Financial score:
- 25/100
- Valuation score:
- 0/100
- Revenue score:
- 19/100
What stands out
- Reported year-over-year revenue growth is +0.1%.
- Free cash flow is $-50.3M, showing cash burn in the current stored period.
- The balance sheet shows $242.8M of cash versus $200.0M of total debt, leaving more cash than debt.
- The latest Wall Street Score change is +0.1 points: CGC increased 0.1 points because overall fundamentals improved.
- The current research record carries a share basis reconciled warning, which should be reviewed alongside the score.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-14.
How to research CGC
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.